Carlsson et al (2000) Flashcards
Aim
Review studies in relationship between neurotransmitter levels on symptoms of schizophrenia (focusing on hyperdopaminergia and hypoglutamatergia)
Look at impact side effects of antipsychotics
Produce drugs that reduce relapse levels and negative side effects
Literature Review
32 studies investigating role of neurotransmitters in development of schizophreia symptoms
Research from 1978-1999
Evidence from studies on recreational drugs that induce psychosis
Link to amphetamines (increase dopamine) with schizophrenia
Type of study they used
Brain scans
Measure neurotransmitters
Recreational drugs
Effectiveness of drugs
Results with PCP
Phencyclidne (PCP) antagonist of NMDA (glutamate) receptors
Drug inhibits glutamate, reducing action in areas of the brain
PCP more likely to result in psychosis than amphetamine
Results with relation between glutamate and symptoms
Low glutamate = psychotic symptoms
Low glutamate = high dopamine
What does glutamate failure result in
Glutamate failure in cerebral cortex = negative symptoms
glutamate failure in basal ganglia = positive symptoms
Results with drug clozapine
Highly effective
Fewer negative side effects
Both antidopaminergic and antiserotonergic functions = low dopamine and serotonin
Reduces positive and negative symptoms
Highly effective in patients not previously responsive to treatment
What patients are difficult to treat
Patients with hypoglutamatergia
Most drugs only change serotonin and dopamine levels
Conclusion (what needs to change about treatment of schizophrenia)
Need to consider other neurotransmitters (like glutamate), don’t just focus on dopamine
Blocking dopamine gives bad side effects so better to look at other neurotransmitters that don’t cause side effects
Many types of schizophrenia caused by abnormal levels of DIFFERENT neurotransmitters to dopamine
Strength Study
Carlsson and Carlsson (1989)
What did Carlsson and Carlsson (1989) find
Gave mice drug to reduce motor activity followed by MK-801 (reduce glutamate and increase serotonin and dopamine)
MK-801 restarted motor activity but continued use resulted in highly abnormal psychotic-like behaviour
Schizophrenia may be caused by glutamate irregularity and glutamate antagonists may be effective treatements
Weakness study
Luhrmann (2015)
What did Luhrmann (2015) find
Luhrmann (2015)
US participants more likely to hear violent voices whereas Ghanian and Indian people heard positive experiences
Ignored cultural factors as conclusions are based on animal models
Animals models fail to capture holistic lives experience of schizophrenia including side effects and symptoms
CA of strength
Since study two neurotransmitters (anadamide and nitric oxide) have been identified as important in psychosis
Leading to new tratments
Also suggested neurotransmitter imbalances may arise from autoimmune problems
Another weakness
Some evidence for dopamine hypothesis based on people with schizophrenia during acute episodes
People with chronic schizophrenia may respond differently with their episodes
Research should consider all phases of disorder to make better conclusions